Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review

Twenty to thirty percent of psoriasis (Pso) patients will develop psoriatic arthritis (PsA). Detection of Pso patients that are (at risk for) developing PsA is essential to prevent structural damage. We conducted a systematic search of five bibliographic databases, up to May 2020. We searched for st...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Michelle L. M., van Hal, Tamara W., Wenink, Mark H., Koenen, Hans J. P. M., van den Hoogen, Frank H. J., de Jong, Elke M. G. J., van den Reek, Juul M. P. A., Vriezekolk, Johanna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201808/
https://www.ncbi.nlm.nih.gov/pubmed/34127053
http://dx.doi.org/10.1186/s13075-021-02545-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201808/
https://www.ncbi.nlm.nih.gov/pubmed/34127053
http://dx.doi.org/10.1186/s13075-021-02545-4

Ejemplares similares